Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Randomized Controlled Trial von Steinhubl, Steven R, Berger, Peter B, Mann III, J. Tift, Fry, Edward T. A, DeLago, Augustin, Wilmer, Charles, Topol, Eric J, for the CREDO Investigators

Volltext

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial) von Lincoff, A.Michael, Bittl, John A, Kleiman, Neal S, Sarembock, Ian J, Jackman, J.Daniel, Mehta, Sameer, Tannenbaum, Mark A, Niederman, Alan L, Bachinsky, William B, Tift-Mann, J, Parker, H.Graham, Kereiakes, Dean J, Harrington, Robert A, Feit, Frederick, Maierson, Elizabeth S, Chew, Derek P, Topol, Eric J

Volltext

Letter to the Editor von Mann III, J. Tift

Volltext

Unprotected left main disease managed with drug-eluting stents: Long-term outcome of 100 patients with increased surgical risk von Wood, Frances O., Saylors, Elizabeth K., Schneider, Joel E., Jobe, R. Lee, Mann III, J. Tift

Volltext

A novel point-of-care enoxaparin monitor for use during percutaneous coronary intervention: Results of the Evaluating Enoxaparin Clotting Times (ELECT) Study von MOLITERNO, David J, HERMILLER, James B, LEVINE, Glenn N, MANN, Tift III, NAIR, Ravi N, STINE, Ronald A, YACUBOV, Steven J, TCHENG, James E, KEREIAKES, Dean J, YOW, Eric, APPLEGATE, Robert J, BRADEN, Gregory A, DIPPEL, Eric J, FURMAN, Mark I, GRINES, Cindy L, KLEIMAN, Neal S

Volltext

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial von Blankenship, James C, Tasissa, Gudaye, O’Shea, J.Conor, Iliadis, Elias A, Bachour, Fouad A, Cohen, David J, Lui, Henry K, Mann, Tift, Cohen, Eric, Tcheng, James E

Volltext